http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 24 Feb 2026 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Press+Releases/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html <p align="justify">SAN DIEGO and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“<strong>Aptose</strong>” or the “<strong>Company</strong>”) (TSX: APS; OTC: APTOF) announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the “<strong>Amended and Restated Arrangement Agreement</strong>”) amending and restating the arrangement agreement dated November 18, 2025 (the “<strong>Original Arrangement Agreement</strong>”), pursuant to which Aptose will continue from the <em>Canada Business Corporations Act</em> to the <em>Business Corporations Act</em> (Alberta) (“<strong>ABCA</strong>”) (the “<strong>Continuance</strong>”) and subsequently be acquired by HS North America Ltd. (the “<strong>Purchaser</strong>”), a wholly owned subsidiary of Hanmi Pharmaceutical http://www.streetinsider.com/Globe+Newswire/Aptose+Biosciences+Announces+Amendment+to+Arrangement+Agreement+and+Details+of+Postponed+Special+Meeting+of+Shareholders/26046502.html Tue, 24 Feb 2026 07:00:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html si-local-file:///var/storage/secattach/20260224/26046089.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html si-local-file:///var/storage/secattach/20260224/26046089.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html si-local-file:///var/storage/secattach/20260224/26046089.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26046089.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html si-local-file:///var/storage/secattach/20260224/26046095.html http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html si-local-file:///var/storage/secattach/20260224/26046095.html http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html si-local-file:///var/storage/secattach/20260224/26046095.html http://www.streetinsider.com/SEC+Filings/Form++DEFM14A++++Aptose+Biosciences+Inc.++++++++++++++/26046095.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html si-local-file:///var/storage/secattach/20260224/26046122.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html si-local-file:///var/storage/secattach/20260224/26046122.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html si-local-file:///var/storage/secattach/20260224/26046122.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aptose+Biosciences+Inc.+++For%3A+Feb+23/26046122.html Tue, 24 Feb 2026 06:03:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html si-local-file:///var/storage/secattach/20260217/26005232.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html Tue, 17 Feb 2026 06:14:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html si-local-file:///var/storage/secattach/20260217/26005232.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html Tue, 17 Feb 2026 06:14:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html si-local-file:///var/storage/secattach/20260217/26005232.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./26005232.html Tue, 17 Feb 2026 06:14:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html si-local-file:///var/storage/secattach/20260217/26005109.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html Tue, 17 Feb 2026 06:11:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html si-local-file:///var/storage/secattach/20260217/26005109.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html Tue, 17 Feb 2026 06:11:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html si-local-file:///var/storage/secattach/20260217/26005109.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/26005109.html Tue, 17 Feb 2026 06:11:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html si-local-file:///var/storage/secattach/20260209/25964382.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html Mon, 09 Feb 2026 06:16:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html si-local-file:///var/storage/secattach/20260209/25964382.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html Mon, 09 Feb 2026 06:16:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html si-local-file:///var/storage/secattach/20260209/25964382.html http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++Aptose+Biosciences+Inc.++++++++++++++++Filed+by%3A+Aptose+Biosciences+Inc./25964382.html Mon, 09 Feb 2026 06:16:00 -0500 APS APTOF O.00674004 http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/25964344.html si-local-file:///var/storage/secattach/20260209/25964344.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++Aptose+Biosciences+Inc.++++++++++++++/25964344.html Mon, 09 Feb 2026 06:07:00 -0500 APS APTOF O.00674004